122 related articles for article (PubMed ID: 2154988)
21. Ribonucleotide reductase from herpes simplex virus (types 1 and 2) infected and uninfected KB cells: properties of the partially purified enzymes.
Ponce de Leon M; Eisenberg RJ; Cohen GH
J Gen Virol; 1977 Jul; 36(1):163-73. PubMed ID: 18550
[TBL] [Abstract][Full Text] [Related]
22. Regulation of ribonucleotide reductase activity in intact mammalian cells.
Hards RG; Wright JA
Arch Biochem Biophys; 1984 May; 231(1):17-28. PubMed ID: 6372693
[TBL] [Abstract][Full Text] [Related]
23. Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase.
Kayyali R; Porter JB; Liu ZD; Davies NA; Nugent JH; Cooper CE; Hider RC
J Biol Chem; 2001 Dec; 276(52):48814-22. PubMed ID: 11602611
[TBL] [Abstract][Full Text] [Related]
24. Hydroxyurea-induced conversion of mammalian ribonucleotide reductase to a form hypersensitive to bleomycin.
McClarty GA; Chan AK; Wright JA
Cancer Res; 1986 Sep; 46(9):4516-21. PubMed ID: 2425956
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus ribonucleotide reductase induced in infected BHK-21/C13 cells: biochemical evidence for the existence of two non-identical subunits, H1 and H2.
Cohen EA; Charron J; Perret J; Langelier Y
J Gen Virol; 1985 Apr; 66 ( Pt 4)():733-45. PubMed ID: 2984316
[TBL] [Abstract][Full Text] [Related]
26. Affinity labeling of ribonucleotide reductase by the 2',3'-dialdehyde derivatives of ribonucleotides.
Tsai PK; Hogenkamp HP
Arch Biochem Biophys; 1983 Oct; 226(1):276-84. PubMed ID: 6357087
[TBL] [Abstract][Full Text] [Related]
27. Ribonucleotide reductase: an important enzyme in the replication of herpes simplex virus type 1 and a target for antiviral chemotherapy.
Prichard MN; Shipman C
Chemotherapy; 1995; 41(5):384-95. PubMed ID: 8521741
[TBL] [Abstract][Full Text] [Related]
28. Escherichia coli and herpes-simplex-virus ribonucleotide reductase R2 subunit. Compared reactivities of the redox centres.
Atta M; Lamarche N; Battioni JP; Massie B; Langelier Y; Mansuy D; Fontecave M
Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):807-10. PubMed ID: 8384445
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of ribonucleotide reductase and L1210 cell growth by N-hydroxy-N'-aminoguanidine derivatives.
Cory JG; Carter GL; Bacon PE; T'ang A; Lien EJ
Biochem Pharmacol; 1985 Aug; 34(15):2645-50. PubMed ID: 3893440
[TBL] [Abstract][Full Text] [Related]
30. Iron chelators target both proliferating and quiescent cancer cells.
Fryknäs M; Zhang X; Bremberg U; Senkowski W; Olofsson MH; Brandt P; Persson I; D'Arcy P; Gullbo J; Nygren P; Schughart LK; Linder S; Larsson R
Sci Rep; 2016 Dec; 6():38343. PubMed ID: 27924826
[TBL] [Abstract][Full Text] [Related]
31. Studies on mammalian ribonucleotide reductase inhibition by pyridoxal phosphate and the dialdehyde derivatives of adenosine, adenosine 5'-monophosphate, and adenosine 5'-triphosphate.
Cory JG; Mansell MM
Cancer Res; 1975 Feb; 35(2):390-6. PubMed ID: 1109803
[TBL] [Abstract][Full Text] [Related]
32. 8-Azidoadenosine and ribonucleotide reductase.
Roy B; Lepoivre M; Decout JL; Lhomme J; Fontecave M
Biochem Biophys Res Commun; 1992 Aug; 187(1):432-7. PubMed ID: 1520331
[TBL] [Abstract][Full Text] [Related]
33. Substrate specificity of human ribonucleotide reductase from Molt-4F cells.
Chang CH; Cheng YC
Cancer Res; 1979 Dec; 39(12):5081-6. PubMed ID: 498135
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell lines.
Hoyes KP; Hider RC; Porter JB
Cancer Res; 1992 Sep; 52(17):4591-9. PubMed ID: 1511427
[TBL] [Abstract][Full Text] [Related]
35. Vaccinia virus-induced ribonucleotide reductase can be distinguished from host cell activity.
Slabaugh MB; Mathews CK
J Virol; 1984 Nov; 52(2):501-6. PubMed ID: 6387174
[TBL] [Abstract][Full Text] [Related]
36. Identification of a herpes simplex virus type 1 polypeptide which is a component of the virus-induced ribonucleotide reductase.
Preston VG; Palfreyman JW; Dutia BM
J Gen Virol; 1984 Sep; 65 ( Pt 9)():1457-66. PubMed ID: 6088678
[TBL] [Abstract][Full Text] [Related]
37. Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides.
Dutia BM; Frame MC; Subak-Sharpe JH; Clark WN; Marsden HS
Nature; 1986 May 22-28; 321(6068):439-41. PubMed ID: 3012359
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of inhibition of mammalian ribonucleotide reductase by the iron chelate of 1-formylisoquinoline thiosemicarbazone. Destruction of the tyrosine free radical of the enzyme in an oxygen-requiring reaction.
Thelander L; Gräslund A
J Biol Chem; 1983 Apr; 258(7):4063-6. PubMed ID: 6300073
[TBL] [Abstract][Full Text] [Related]
39. Ribonucleotide reductase, lipoxygenase and the intracellular low-molecular-weight iron pool.
Cooper CE; Porter JB
Biochem Soc Trans; 1997 Feb; 25(1):75-80. PubMed ID: 9056847
[No Abstract] [Full Text] [Related]
40. Neutralization of herpes simplex virus ribonucleotide reductase activity by an oligopeptide-induced antiserum directed against subunit H2.
Cohen EA; Gaudreau P; Brazeau P; Langelier Y
J Virol; 1986 Dec; 60(3):1130-3. PubMed ID: 2431161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
